Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial,”1 an incorrect analysis of the mean deviations for visual field loss over time led to errors in eTable 6 in Supplement 3. These errors did not affect the conclusions of the article. A Letter of Explanation2 has been published that details the source of these errors. This article has been corrected online.
Errors in eTable 6 in the Supplement. JAMA Ophthalmol. 2019;137(4):467. doi:10.1001/jamaophthalmol.2019.0032
Create a personal account or sign in to: